Cargando…
Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials
Background: Nicorandil prior to reperfusion by primary percutaneous coronary intervention (PCI) in patients with ST-segment elevated myocardial infarction (STEMI) has been suggested to be beneficial. However, results of previous randomized controlled trials (RCTs) were not consistent. We aimed to pe...
Autores principales: | Xu, Li, Wang, Lefeng, Li, Kuibao, Zhang, Zhiyong, Sun, Hao, Yang, Xinchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499143/ https://www.ncbi.nlm.nih.gov/pubmed/31118574 http://dx.doi.org/10.2147/DDDT.S195918 |
Ejemplares similares
-
Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials [Letter]
por: Li, Jun, et al.
Publicado: (2019) -
Impact of administration of nicorandil prior to percutaneous coronary intervention in treatment of acute myocardial infarction: A protocol for systematic review and meta-analysis
por: Li, Weijun, et al.
Publicado: (2021) -
Effect of nicorandil administration on myocardial microcirculation during primary percutaneous coronary intervention in patients with acute myocardial infarction
por: Feng, Chunguang, et al.
Publicado: (2018) -
Nicorandil in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
por: Wu, Muli, et al.
Publicado: (2013) -
Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention
por: Zhao, Xiao-Tao, et al.
Publicado: (2019)